| Literature DB >> 33489611 |
Ratan Kumar1, Kheraj Mal2, Muhammad Khalid Razaq3, Mansoor Magsi4, Muhammad Khizar Memon5, Sidra Memon6, Sana Irfan6, Kanwal Bansari6, Basma Ali6, Amber Rizwan7.
Abstract
Introduction Percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) are two common treatment options used in patients suffering from coronary artery disease. Selection and favorability of one over the other depend on individual clinical scenarios. The purpose of this study is to compare outcomes after treatment with PCI and CABG. Methods This longitudinal observational study was conducted from April 2018 to July 2019 in a cardiovascular unit of a tertiary care hospital. Participants who were eligible for revascularization were randomized either to receive stent (PCI) or surgery (CABG). Patients were then followed up for 12 months for the development of all-cause mortality and major adverse cardiovascular events (MACEs). Results At 12 months, patients randomized to the PCI group had an increased risk of repeat revascularization (21.3% vs. 7.4%; p = 0.007), whereas a similar number of patients in both groups died (3.8% vs. 3.7%), suffered myocardial infarction (7.6% vs. 5.6%), or had a cerebrovascular accident (3.8% vs. 2.8%). Conclusions This study showed that PCI had an increased risk of repeat revascularization compared to CABG. However, both had comparable significance in the development of MACEs. Nevertheless, there is a need for further study to better assess the outcomes of either, especially in the long run.Entities:
Keywords: coronary artery bypass grafting; myocardial infarction; percutaneous coronary intervention
Year: 2020 PMID: 33489611 PMCID: PMC7815293 DOI: 10.7759/cureus.12202
Source DB: PubMed Journal: Cureus ISSN: 2168-8184